Synthesis and cytotoxicity evaluation of 1-[3-(9H-carbazol-4-yloxy)-2- hydroxypropyl]-3-aryl-1H-pyrazole-5-carboxylic acid derivatives

European Journal of Medicinal Chemistry

Volumn 45, Issue 11, 2010, Pages 4720-4725

  Nagarapu, Lingaiah ^a   Gaikwad, Hanmant K ^a   Sarikonda, Kartheeka ^a   Mateti, Jhansi ^a   Bantu, Rajashaker ^a   Raghu, P S ^a   Manda, Krishna Madhuri ^a   Kalvendi, Shasi Vardhan ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

A549 cell line; Cytotoxicity; Growth inhibition; MCF 7 cell line; Neuroblastoma cell line (SK N SH); Pyrazole carbazole derivatives

Indexed keywords

1 [3 (9H CARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 (3 METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLIC ACID; 1 [3 (9H CARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 (3 NITROPHENYL) 1H PYRAZOLE 5 CARBOXYLIC ACID; 1 [3 (9H CARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 (4 METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLIC ACID; 1 [3 (9H CARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 (4 NITROPHENYL) 1H PYRAZOLE 5 CARBOXYLIC ACID; 1 [3 (9H CARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 2 TOLYL 1H PYRAZOLE CARBOXYLIC ACID; 1 [3 (9H CARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 4 TOLYL 1H PYRAZOLE 5 CARBOXYLIC ACID; 1 [3 (9HCARBAZOL 4 YLOXY) 2 HYDROXYPROPYL] 3 (3 NITROPHENYL) 1H PYRAZOLE 5 CARBOXYLIC ACID; CARBAZOLE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; ETHYL 3 (2 NITROPHENYL) 1H PYRAZOLE 5 CARBOXYLATE; ETHYL 3 (3 METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE; ETHYL 3 (3 NITROPHENYL) 1H PYRAZOLE 5 CARBOXYLATE; ETHYL 3 (4 METHOXYPHENYL) 1H PYRAZOLE 5 CARBOXYLATE; ETHYL 3 (4 NITROPHENYL) 1H PYRAZOLE 5 CARBOXYLATE; ETHYL 3 2 TOLYL 1H PYRAZOLE 5 CARBOXYLATE; ETHYL 3 4 TOLYL 1H PYRAZOLE 5 CARBOXYLATE; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HETERONUCLEAR NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; NEUROBLASTOMA; STRUCTURE ACTIVITY RELATION;

CARBOXYLIC ACIDS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PYRAZOLES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 77957840323     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.07.004     Document Type: Article

References (11)

1. G.M. Brodeur, P.A. Pizzo, D.G. Poplack, Principles and Practice of Pediatric Oncology (Neuroblastoma) 4th edn. 2001 Lippencoot-Raven Philadelphia 895 937
2. M. Viale, M.A. Mariggio, M. Ottone, B. Chiavarina, A. Vinella, and C. Prevosto Invest. New. Drugs. 22 2004 359
3. R.H. Bradury, Cancer in "Topics in Medicinal Chemistry" vol. 1 2007 Springer-Verlag berlin Heidelberg
4. S. Routier, J.-Y. Merour, N. Dias, N. Lansiaux, C. Bailly, and O. Lozach J. Med. Chem. 49 2006 789 799
5. L. Hu, Y.-R. Li, Y. Li, J. Qu, Y.-H. Ling, and J.-D. Jiang J. Med. Chem. 49 2006 6273 6282
6. L. Nagarapu, V. Paparaju, and A. Satyender Bioorg. Med. Chem. Lett. 18 2008 2351 2354
7. L. Nagarapu, A. Satyender, B. Rajashaker, P. Srinivas, Rupa Rani, and K. Radhika Bioorg. Med. Chem. Lett. 18 2008 1167 1171
8. S. Sidique, R. Ardecky, Y. Su, S. Narisawa, B. Brown, and J.L. Millan Bioorg. Med. Chem. Lett. 19 2009 222 225
9. P. Skehan, D. Storeng, A. Scudiero, J. Monks, D. McMahon, and J.T. Vistica J. Natl. Cancer. Inst. 82 1990 1107 1112
10. L.V. Rubinstein, R.H. Shoemaker, K.D. Paull, S. Simon, P. Tosini, and D. Skehan J. Natl. Cancer. Inst. 82 1990 1113 1118
11. S.K. Lee, B. Cui, R.R. Mehta, A.D. Kinghorn, and J.M. Pezzuto Chem. Biol. Interact. 115 1998 215